Company profile: Sterigenics
1.1 - Company Overview
Company description
- Provider of contract sterilization and ionization supply chain management solutions for medical device and pharmaceutical industries, using Ethylene Oxide (EO), Gamma and Electron Beam (E-Beam) irradiation. Also offers process capabilities for food safety and high performance specialty materials, VeriCycle automated EO process verification, and Sterigenics GPS end-to-end, real-time global processing status visibility.
Products and services
- Electron Beam (E-Beam) Sterilization: A high-dosage-rate, low-penetration ionizing energy service suitable for low-density, uniformly packaged products and material modification, using electron beams
- Ethylene Oxide (EO) Sterilization: An industrial-grade gas diffusion process that sterilizes a wide range of medical products and devices by reacting with and destroying microbial DNA using ethylene oxide gas
- Gamma Irradiation: A deep-penetration Cobalt-60 irradiation service that deeply penetrates products and their packaging, effectively killing microorganisms with minimal temperature effect and no residues
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Sterigenics
Jubilee Clinical Research
HQ: United States
Website
- Description: Provider of clinical research across diverse indications, including new antibiotic developments and the latest diabetic therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Jubilee Clinical Research company profile →
Phastar
HQ: United Kingdom
Website
- Description: Provider of specialist biometrics contract research services, offering statistical consulting, clinical trial reporting, data management, and data science for clinical trials. Also provides rescue trial support and functional services partnerships via expert consultants, in-house projects, FSP-style arrangements, and preferred partnerships.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Phastar company profile →
Aquila BioMedical
HQ: United Kingdom
Website
- Description: Provider of pre-clinical contract research services with expertise in immuno-oncology, immunology, and multiplex histology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aquila BioMedical company profile →
Trinity Life Sciences
HQ: United States
Website
- Description: Provider of strategic and tactical insights for pharmaceutical and biotech, offering Trinity Infinity for integrated strategy, insights, and analytics; Customer Engagement Solutions; Trinity Real Insights predictive insights integrating market research and real-world data; Brand Insights AI; comprehensive market research; and pricing studies to optimize clinical and commercial decision-making.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Trinity Life Sciences company profile →
Northeast Biolab
HQ: United States
Website
- Description: Provider of GLP and clinical bioanalysis services with 15+ years of experience, offering method development, validation and transfer; LC-MS bioanalysis; pharmacokinetics sample analysis and toxicokinetic safety testing; and assay platforms including ELISA, MSD, qPCR/ddPCR, Western Blot and In Cell Western for drug testing and biomarker analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Northeast Biolab company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Sterigenics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Sterigenics
2.2 - Growth funds investing in similar companies to Sterigenics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Sterigenics
4.2 - Public trading comparable groups for Sterigenics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →